Wen Shi, Jieru Huang, Dong-dong Liu, M. He, Chu-Wei Zheng, Qian Xiao, Li Lin, Yile Huang, Lin Li, Jianhua Xu
{"title":"应用新指南CLSI EP7-A3评价肌酐测量中的干扰因素","authors":"Wen Shi, Jieru Huang, Dong-dong Liu, M. He, Chu-Wei Zheng, Qian Xiao, Li Lin, Yile Huang, Lin Li, Jianhua Xu","doi":"10.3760/CMA.J.ISSN.1009-9158.2020.03.021","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the interfering factors in the determination of creatinine(Cr) using the American Clinical Laboratory Standards Association (CLSI) EP7-A3 document. \n \n \nMethods \nAccording to the CLSI EP7-A3 document, fresh serum (no hemolysis, lipemia, and jaundice) was used on the day of the experiment and confirmed the interfering substances through the pairing difference experiment and the point-to-point analysis method was used in the dose effect experiment to clarify the difference of interfering substances. \n \n \nResults \nTriglyceride (16.94 mmol/L), dobutamine hydrochloride (4.01 μmol/L), ascorbic acid (298 μmol/L) did not interfere with the determination of Cr. Free bilirubin (684 μmol/L), conjugated bilirubin (684 μmol/L), calcium hydroxybenzene sulfonate (144 μmol/L) and hemoglobin (10 g/L) were used as the maximum concentrations of interferences for the dose effect test, the results showed that the above interferences had negative interference on the determination of Cr. \n \n \nConclusion \nAccording to EP7-A3, it is valuable to evaluate the interference factors of creatinine determination. \n \n \nKey words: \nInterference experiment; Creatinine","PeriodicalId":10096,"journal":{"name":"中华检验医学杂志","volume":"67 16 1","pages":"307-311"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of interference factors in creatinine measurement by using new guideline CLSI EP7-A3\",\"authors\":\"Wen Shi, Jieru Huang, Dong-dong Liu, M. He, Chu-Wei Zheng, Qian Xiao, Li Lin, Yile Huang, Lin Li, Jianhua Xu\",\"doi\":\"10.3760/CMA.J.ISSN.1009-9158.2020.03.021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo investigate the interfering factors in the determination of creatinine(Cr) using the American Clinical Laboratory Standards Association (CLSI) EP7-A3 document. \\n \\n \\nMethods \\nAccording to the CLSI EP7-A3 document, fresh serum (no hemolysis, lipemia, and jaundice) was used on the day of the experiment and confirmed the interfering substances through the pairing difference experiment and the point-to-point analysis method was used in the dose effect experiment to clarify the difference of interfering substances. \\n \\n \\nResults \\nTriglyceride (16.94 mmol/L), dobutamine hydrochloride (4.01 μmol/L), ascorbic acid (298 μmol/L) did not interfere with the determination of Cr. Free bilirubin (684 μmol/L), conjugated bilirubin (684 μmol/L), calcium hydroxybenzene sulfonate (144 μmol/L) and hemoglobin (10 g/L) were used as the maximum concentrations of interferences for the dose effect test, the results showed that the above interferences had negative interference on the determination of Cr. \\n \\n \\nConclusion \\nAccording to EP7-A3, it is valuable to evaluate the interference factors of creatinine determination. \\n \\n \\nKey words: \\nInterference experiment; Creatinine\",\"PeriodicalId\":10096,\"journal\":{\"name\":\"中华检验医学杂志\",\"volume\":\"67 16 1\",\"pages\":\"307-311\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华检验医学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1009-9158.2020.03.021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Health Professions\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华检验医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1009-9158.2020.03.021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Health Professions","Score":null,"Total":0}
Evaluation of interference factors in creatinine measurement by using new guideline CLSI EP7-A3
Objective
To investigate the interfering factors in the determination of creatinine(Cr) using the American Clinical Laboratory Standards Association (CLSI) EP7-A3 document.
Methods
According to the CLSI EP7-A3 document, fresh serum (no hemolysis, lipemia, and jaundice) was used on the day of the experiment and confirmed the interfering substances through the pairing difference experiment and the point-to-point analysis method was used in the dose effect experiment to clarify the difference of interfering substances.
Results
Triglyceride (16.94 mmol/L), dobutamine hydrochloride (4.01 μmol/L), ascorbic acid (298 μmol/L) did not interfere with the determination of Cr. Free bilirubin (684 μmol/L), conjugated bilirubin (684 μmol/L), calcium hydroxybenzene sulfonate (144 μmol/L) and hemoglobin (10 g/L) were used as the maximum concentrations of interferences for the dose effect test, the results showed that the above interferences had negative interference on the determination of Cr.
Conclusion
According to EP7-A3, it is valuable to evaluate the interference factors of creatinine determination.
Key words:
Interference experiment; Creatinine